Virote Sriuranpong - Internal Medicine, Faculty of Medicine, Chulalongkorn University, Patumwan, Thailand

基本信息

浏览量：154

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 46 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial

A T C Chan,V H F Lee,R-L Hong,M-J Ahn,W Q Chong,S-B Kim,G F Ho, P B Caguioa,N Ngamphaiboon,C Ho, M A S A Aziz,Q S Ng,

Annals of Oncology（2023）

引用15浏览0WOS引用

EUS-guided radiofrequency ablation plus chemotherapy versus chemotherapy alone for pancreatic cancer (ERAP): An observational open-label pilot study

Pradermchai Kongkam,Kasenee Tiankanon,Dong Wan Seo,Thanawat Luangsukrerk,Virote Sriuranpong,Chonnipa Nantavithya, Trirat Jantarattana,Arlyn Canones,Stephen J. Kerr,Kittithat Tantitanawat,Phonthep Angsuwatcharakon,Wiriyaporn Ridtitid,

ENDOSCOPIC ULTRASOUNDno. 5 (2023): 402-408

引用0浏览0引用

Clinical Benefit of First-Line Cemiplimab in Patients with Locally Advanced NSCLC: Subgroup Analysis from EMPOWER-Lung 1

I. Bondarenko,A. Sezer,S. Kilickap,M. Gumus,M. Ozguroglu, M. Gogishvili,H. M. Turk,I. Cicin,D. Bentsion,O. Gladkov, P. Clingan,V. Sriuranpong,

JOURNAL OF THORACIC ONCOLOGY（2021）

引用0浏览0引用

Paloma-4: Primary Results From A Phase Iii Trial Of Palbociclib (Pal) Plus Letrozole (Let) Vs Placebo (Pbo) Plus Let In Asian Postmenopausal Women With Estrogen Receptore Positive/Human Epidermal Growth Factor Receptor 2-Negative (Er+/Her2-) Advanced Breast Cancer (Abc)

B. Xu, X. Hu,W. Li, T. Sun, K. Shen,S. Wang,Y. Cheng, Q. Zhang, S. Cui, Z. Tong, C. Geng,C-S. Huang,

ANNALS OF ONCOLOGY（2021）

引用10浏览0引用

Eus-guided radiofrequency ablation plus chemotherapy versus chemotherapy alone for unresectable pancreatic cancer (erap): preliminary results of a prospective comparative study

K Tiankanon,P Kongkam, T Orprayoon,T Luangsukrerk,DW Seo,V Sriuranpong,C Nantavithya,T Jantarattana, A Cañones,P Angsuwatcharakon,W Ridtitid,P Kullavanijaya,

ESGE Days 2019Endoscopy（2019）

引用1浏览0引用

BOLERO-4: Multicenter, open-label, phase II study of everolimus plus letrozole as first-line therapy in ER+, HER2- metastatic breast cancer

William J. Gradishar,Thomas Bachelot,Stephen Saletan, Anne Marie Graham,Pedro Emanuel Rubini Liedke,Sergio Jobim de Azevedo,Virote Sriuranpong,Fatima Cardoso

Journal of Clinical Oncology（2017）

引用11浏览0引用

92O Everolimus (EVE)+ letrozole (LET) in Asian patients with estrogen receptor–positive (ER+), human epidermal growth factor receptor 2–negative (HER2−) advanced breast cancer …

T Toyama, J Jeong, V Srimuninnimit,V Sriuranpong, W Noh, K Tsugawa, M Takahashi, H Iwase, C Arce, A Ridolfi,C Lin, M Royce,

Annals of Oncologyno. suppl_10 (2017): mdx654

引用1浏览0引用

Stomatitis In Patients Treated With First-Line Everolimus (Eve) Plus Letrozole (Let): Results From Bolero-4 Trial

C Villanueva, K Tsugawa,T Toyama, W Noh,J Jeong, F Cardoso,V Sriuranpong,V Srimuninnimit,M Ozguroglu, S Kendall,C Falkson, M Cianfrocca,

CANCER RESEARCH（2017）

引用1浏览0引用

Abstract P2-11-08: Stomatitis in patients treated with first-line everolimus (EVE) plus letrozole (LET): Results from BOLERO-4 trial

C Villanueva, K Tsugawa,T Toyama, W Noh, J Jeong,F Cardoso,V Sriuranpong, V Srimuninnimit,M Ozguroglu, S Kendall, C Falkson, M Cianfrocca,

Poster Session Abstracts (2017)

引用0浏览0引用

92OEverolimus (EVE) + letrozole (LET) in Asian patients with estrogen receptor–positive (ER+), human epidermal growth factor receptor 2–negative (HER2−) advanced breast cancer (ABC): Results of a subgroup analysis from the BOLERO-4 study

T Toyama,J Jeong,V Srimuninnimit,V Sriuranpong,W Noh, K Tsugawa, M Takahashi,H Iwase,C Arce, A Ridolfi,C Lin,M Royce,

Annals of Oncology（2017）

引用2浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn